MAY 19, 2020 6:30 AM PDT

The Mystery of the Life-Saving Vaccine Solved

WRITTEN BY: Tara Fernandez

 

In the early 1900s, French bacteriologists Albert Calmette and Camille Guérin spent the better half of a decade developing a vaccine that protects infants and young children from succumbing to potentially lethal forms of tuberculosis (TB). Today, this 100-year-old vaccine known as Bacillus Calmette-Guérin, or BCG, is still among the safest and cheapest clinically-available vaccines. 

 

For reasons that have mystified scientists, the BCG vaccine has an added advantage beyond TB-protection. Upon administration, it also prevents newborn deaths from diseases other than TB. In fact, the vaccine slashes the risk of mortality from infections by almost 50 percent. The immunological mechanism behind this, however, has remained a black box.

 

Researchers from the University of British Columbia believe they have found the missing piece to the puzzle: white blood cells called neutrophils. The world’s first study, published in Science Translational Medicine, describes how BCG vaccination triggers a rapid spike in circulating neutrophils, which safeguards the body from invading pathogens.

 

The role that neutrophils play in resisting infection is well understood, but how the BCG vaccine initiates this protective shield was unknown. As senior co-author Nelly Amenyogbe explained, “It was actually thought to be biologically implausible, however we’ve not only shown how BCG is involved, but that it kicks off this process almost instantly following vaccination — far more quickly than anticipated.”

 

With this discovery, the authors believe that making BCG vaccination standard for newborns across the globe could dramatically reduce infant mortality, particularly in low- and middle-income regions.

 

The researchers are currently testing BCG’s potential in protecting individuals against COVID-19. Live attenuated vaccines, such as BCG can trigger a robust systemic immune response which could potentially enhance protection against other pathogenic infections. This hypothesis is being tested in ongoing clinical trials across Australia and the Netherlands.

 


Source: University of British Columbia, Science Translational Medicine.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
MAY 26, 2020
Drug Discovery & Development
Everyone Can Produce Antibodies Against COVID-19
MAY 26, 2020
Everyone Can Produce Antibodies Against COVID-19
Researchers at Rockefeller University in New York have found that most people exposed to COVID-19, and who experience sy ...
JUN 15, 2020
Immunology
Experimental MS Treatment Relies on "Retraining" the Immune System
JUN 15, 2020
Experimental MS Treatment Relies on "Retraining" the Immune System
When the immune system goes awry and fails to regulate itself, immune cells may attack the body’s own tissues. Sci ...
JUN 20, 2020
Cell & Molecular Biology
Antibodies Isolated From COVID-19 Patients Show Therapeutic Potential
JUN 20, 2020
Antibodies Isolated From COVID-19 Patients Show Therapeutic Potential
Communities worldwide are emerging from lockdowns due to the SARS-CoV-2 pandemic virus, and cases are rising.
JUL 14, 2020
Coronavirus
What Makes A Strong Antibody Response to Coronavirus
JUL 14, 2020
What Makes A Strong Antibody Response to Coronavirus
Scientists all over the world are racing to develop a vaccine that effectively and safely prompts protective immunity to ...
SEP 14, 2020
Microbiology
The Immune System Can Kill HIV with a Helper Molecule
SEP 14, 2020
The Immune System Can Kill HIV with a Helper Molecule
HIV attacks the human immune system's CD4 cells, a major player in the body's defense against pathogens.
SEP 15, 2020
Immunology
Common Spice Relieves Eye Inflammation in Dogs, Human Studies to Follow
SEP 15, 2020
Common Spice Relieves Eye Inflammation in Dogs, Human Studies to Follow
A therapeutic made from turmeric has been shown to help reduce the effects of a painful inflammatory eye condition in do ...
Loading Comments...